Abstract: A method of making a shock tower assembly includes forming a bracket from continuous fiber reinforced thermoplastic, where the bracket has a load bearing portion and an overmolded portion. The method further includes placing the bracket in an injection tool, injecting a polymer composite material into the injection tool to surround the and overmolded portion of the bracket, and removing a finished component from the injection tool, wherein the finished component comprises the load bearing portion of the bracket extending outwardly from the finished component and the overmolded portion of the bracket that is surrounded by the polymer composite material.

Abstract: A structural part for a body in white of a vehicle includes a frame formed by at least two branches connected to one another in at least one connecting zone and separated from each other by at least one gap in a zone of least stress. The frame is made of a first composite material comprising a plurality of continuous fibers impregnated with a first polymeric material. A body is integral with the frame extending in the gap and connecting the two branches in the zone of least stress. The body is made of a second material that is different from the first composite material and comprises at least a second polymeric material, wherein the body is integral with the branches.

Abstract: A shock tower assembly includes a shock tower body comprised of a polymer composite material, at least one reinforcement member integrated into the shock tower body, and a wheel cover comprised of the polymer composite material and integrated into the shock tower body to form a single-piece component.

Abstract: A shock tower assembly includes a shock tower body comprised of a polymer composite material, at least one reinforcement member integrated into the shock tower body, and a wheel cover comprised of the polymer composite material and integrated into the shock tower body to form a single-piece component.

Abstract: A structural part for a body in white of a vehicle includes a frame formed by at least two branches connected to one another in at least one connecting zone and separated from each other by at least one gap in a zone of least stress. The frame is made of a first composite material comprising a plurality of continuous fibers impregnated with a first polymeric material. A body is integral with the frame extending in the gap and connecting the two branches in the zone of least stress. The body is made of a second material that is different from the first composite material and comprises at least a second polymeric material, wherein the body is integral with the branches.

Abstract: A method of making a shock tower assembly includes forming a bracket from continuous fiber reinforced thermoplastic, where the bracket has a load bearing portion and an overmolded portion. The method further includes placing the bracket in an injection tool, injecting a polymer composite material into the injection tool to surround the and overmolded portion of the bracket, and removing a finished component from the injection tool, wherein the finished component comprises the load bearing portion of the bracket extending outwardly from the finished component and the overmolded portion of the bracket that is surrounded by the polymer composite material.

Abstract: A method for producing polymeric balls or polymeric beads doped with at least one metal element is provided. The method may comprise the following steps: a) a step for forming polymeric balls or beads by polymerization, in an organic phase comprising a polymerization initiator, of at least one ethylenic monomer comprising at least one chelating ligand of at least one metal element; and b) a step for putting said polymeric balls or beads in contact with a solution comprising at least one metal element.

Abstract: The invention relates to a process for preparing a polymeric material doped with metal elements, comprising a step of polymerization of at least one monomer comprising at least one ethylenic function, said monomer being complexed with a metal element. Use of the materials obtained by means of this process as catalysts, or luminescent or magnetic materials, or as elements for laser targets.

Abstract: A method for producing polymeric balls or polymeric beads doped with at least one metal element is provided. The method may comprise the following steps: a) a step for forming polymeric balls or beads by polymerization, in an organic phase comprising a polymerization initiator, of at least one ethylenic monomer comprising at least one chelating ligand of at least one metal element; and b) a step for putting said polymeric balls or beads in contact with a solution comprising at least one metal element.

Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.

Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.

Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.

Abstract: The present invention describes a synthetic non-viral vector composition for gene therapy and the use of such compositions for in vitro, ex vivo and/or in vivo transfer of genetic material. The invention proposes a pharmaceutical composition containing 1) a non-cationic amphiphilic molecule or macromolecule and its use for delivery of nucleic acids or 2) a cationic amphiphilic molecule or macromolecule that transforms from a cationic entity to an anionic, neutral, or zwitterionic entity by a chemical, photochemical, or biological reaction and its use for delivery of nucleic acids. Moreover this invention describes the use of these non-viral vector compositions in conjunction with a surface to mediate the delivery of nucleic acids. An additional embodiment is the formation of a hydrogel with these compositions and the use of this hydrogel for the delivery of genetic material. A further embodiment of this invention is the use of a change in ionic strength for the delivery of genetic material.

Abstract: The secure computer system comprises at least one computer having a processor operating under the control of a program on input data that can be associated with a code and delivering output data for output members. A security peripheral that is external but connected to the processor is provided to receive at least the input data codes, the operands, and the nature of the operation of each elementary operation performed by the processor, a code being calculated on each elementary operation performed by the processor in order to verify proper performance of all or part of the executed program. The system is applicable to processes for automatically running rail track systems.

Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.

Abstract: The present invention describes a synthetic non-viral vector composition for gene therapy and the use of such compositions for in vitro, ex vivo and/or in vivo transfer of genetic material. The invention proposes a pharmaceutical composition containing 1) a non-cationic amphiphilic molecule or macromolecule and its use for delivery of nucleic acids or 2) a cationic amphiphilic molecule or macromolecule that transforms from a cationic entity to an anionic, neutral, or zwitterionic entity by a chemical, photochemical, or biological reaction and its use for delivery of nucleic acids. Moreover this invention describes the use of these non-viral vector compositions in conjunction with a surface to mediate the delivery of nucleic acids. An additional embodiment is the formation of a hydrogel with these compositions and the use of this hydrogel for the delivery of genetic material. A further embodiment of this invention is the use of a change in ionic strength for the delivery of genetic material.

Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.

Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.

Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.